J23 — HCPCS Level II Codes

• J2300 Injection, nalbuphine hydrochloride, per 10 mg billable
• J2305 Injection, nitroglycerin, 5 mg billable
• J2312 Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg billable
• J2313 Injection, naloxone hydrochloride (zimhi), 0.01 mg billable
• J2315 Injection, naltrexone, depot form, 1 mg billable
• J2320 Injection, nandrolone decanoate, up to 50 mg billable
• J2323 Injection, natalizumab, 1 mg billable
• J2325 Injection, nesiritide, 0.1 mg billable
• J2326 Injection, nusinersen, 0.1 mg billable
• J2327 Injection, risankizumab-rzaa, intravenous, 1 mg billable
• J2329 Injection, ublituximab-xiiy, 1mg billable
• J2350 Injection, ocrelizumab, 1 mg billable
• J2351 Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq billable
• J2353 Injection, octreotide, depot form for intramuscular injection, 1 mg billable
• J2354 Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg billable
• J2355 Injection, oprelvekin, 5 mg billable
• J2356 Injection, tezepelumab-ekko, 1 mg billable
• J2357 Injection, omalizumab, 5 mg billable
• J2358 Injection, olanzapine, long-acting, 1 mg billable
• J2359 Injection, olanzapine, 0.5 mg billable
• J2360 Injection, orphenadrine citrate, up to 60 mg billable
• J2361 Injection, depemokimab-ulaa, 1 mg billable
• J2371 Injection, phenylephrine hydrochloride, 20 micrograms billable
• J2372 Injection, phenylephrine hydrochloride (biorphen), 20 micrograms billable
• J2373 Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms billable
• J2374 Apraclonidine hydrochloride ophthalmic, 1% solution, 0.1 ml billable